Skip to main content

Table 1 Patient characteristics and outcome parameters

From: The course of diaphragm atrophy in ventilated patients assessed with ultrasound: a longitudinal cohort study

Age (median, IQR) 67 (55-75)
Male/female 33/20
SAPS II (median, IQR) 72 (63-80)
ICU mortality (n, %) 20 (38)
Maximal change in thickness (mean %, 95 % CI) 32 (27-37)
Aminoglycoside (AG) use (n, %) 15 (28)
 Maximal change in thickness in AG subgroup (mean %, SD) 38 (18)
 Maximal change in thickness in non-AG subgroup (mean %, SD) 30 (18)
P 0.367
Corticosteroids (CS) use (n, %) 26 (49)
 Maximal change in thickness in CS subgroup (mean %, SD) 34 (17)
 Maximal change in thickness in non-CS subgroup (mean %, SD) 29 (19)
P 0.160
Continuous neuromuscular blocking agents administration (n, %) 14 (28)
Single dose or more of neuromuscular blocking agents administration (n, %) 35 (66)
Sepsis on admission (n, %) 25 (47)
 Maximal change in thickness in sepsis subgroup (%, SD) 35 (28-42)
Sepsis during ICU stay (n, %) 45 (85)
  1. IQR interquartile range, SAPS II Simplified Acute Physiology Score II, ICU intensive care unit, CI confidence interval, SD standard deviation